The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cancer treatment and survivorship statistics, 2019
Open accessAbstract
The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau. Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types. Cancer‐related and treatment‐related short‐term, long‐term, and late health effects are also briefly described. More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone. The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost two‐thirds (64%) are aged 65 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow‐up care providers. Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Self-citationHaugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405095 · Cited by 3,028
Self-citation
Cited by
American Cancer Society nutrition and physical activity guideline for cancer survivors
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21719 · Cited by 741
Senescent Cells in Cancer Therapy: Friends or Foes?
Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
Potential Health Benefit of Garlic Based on Human Intervention Studies: A Brief Overview
Ansary, J., Forbes-Hernández, T. Y., Gil, E., Cianciosi, D., Zhang, J., Elexpuru-Zabaleta, M., Simal-Gandara, J., Giampieri, F., & Battino, M. (2020) · Antioxidants · doi:10.3390/antiox9070619 · Cited by 217
Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R. T., Curigliano, G., Felip, E., Ferreira, A. R., Ganz, P. A., Hegarty, J., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.1941 · Cited by 208
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16318 · Cited by 163
Wang, L., Cohen, J. C., Devasenapathy, N., Hong, B. Y., Kheyson, S., Lu, D., Oparin, Y., Kennedy, S. A., Romerosa, B., Arora, N., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.04.088 · Cited by 142
Understanding and supporting informal cancer caregivers
Molassiotis, A., & Wang, M. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00955-3 · Cited by 138
Antoni, M. H., Moreno, P. I., & Penedo, F. J. (2023) · Annual Review of Psychology · doi:10.1146/annurev-psych-030122-124119 · Cited by 132
Radiotheranostics in oncology: Making precision medicine possible
Aboagye, E. O., Barwick, T. D., & Haberkorn, U. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21768 · Cited by 131
Addressing the needs of cancer survivors during the COVID-19 pandemic.
Nekhlyudov, L., Duijts, S., Hudson, S. V., Jones, J. M., Keogh, J., Love, B., Lustberg, M., Smith, K. C., Tevaarwerk, A., Yu, X., et al. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00884-w · Cited by 130
Mathew, A., Doorenbos, A. Z., Jang, M. K., & Hershberger, P. E. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00938-z · Cited by 91
Factors Correlated With Fear of Cancer Recurrence in Cancer Survivors: A Meta-analysis
Zhang, X., Sun, D., Qin, N., Liu, M., Jiang, N., & Li, X. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001020 · Cited by 90
Sex-Specific Cardiovascular Risks of Cancer and Its Therapies
Wilcox, N. S., Rotz, S. J., Mullen, M., Song, E. J., Ky Hamilton, B., Moslehi, J., Armenian, S. H., Wu, J. C., Rhee, J.-W., & Ky, B. (2022) · Circulation Research · doi:10.1161/circresaha.121.319901 · Cited by 86
Overcoming Resistance to Drugs Targeting KRAS Mutation
Jiao, D., & Yang, S. (2020) · The Innovation · doi:10.1016/j.xinn.2020.100035 · Cited by 61
Chen, B. T., Chen, Z., Ye, N., Mambetsariev, I., Fricke, J., Daniel, E., Wang, G., Wong, C. W., Rockne, R. C., Colen, R. R., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00593 · Cited by 63
Hutchcraft, M. L., Teferra, A. A., Montemorano, L., & Patterson, J. G. (2021) · LGBT Health · doi:10.1089/lgbt.2020.0185 · Cited by 47
Prevalence of Depression and Cancer – A systematic review
Riedl, D., & Schuessler, G. (2022) · Zeitschrift für Psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2021.67.oa11 · Cited by 44
Cohee, A., Johns, S. A., Alwine, J. S., Talib, T., Monahan, P. O., Stump, T. E., Cella, D., & Champion, V. L. (2021) · Psycho-Oncology · doi:10.1002/pon.5663 · Cited by 39
Boehmer, U., Jesdale, B. M., Streed, C. G., & Agénor, M. (2022) · Cancer · doi:10.1002/cncr.33915 · Cited by 38
Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts
Zhu, Cheng, M., Yang, Z., Zeng, C., Chen, J., Xie, Y., Luo, S., Zhang, K., Zhou, S.-F., & Lv, N. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s71466 · Cited by 38
Fang, Z., Wang, X., Sun, Y., Fan, R., Liu, Z., Guo, R., & Xie, D. (2019) · Nanoscale · doi:10.1039/c9nr07391d · Cited by 33
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Janssen, F. W., Lak, N. S. M., Janda, C. Y., Kester, L. A., Meister, M. T., Merks, J. H. M., van den Heuvel-Eibrink, M. M., van Noesel, M. M., Zsiros, J., Tytgat, G. A. M., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00657-z · Cited by 32
Song, G., Wang, L., Tang, J., Li, H., Pang, S., Li, Y., Liu, L., & Hu, J. (2023) · Metabolomics · doi:10.1007/s11306-023-02002-0 · Cited by 25
Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer
Feng, J., Jiang, W., Liu, Y., Huang, W., Hu, K., Li, K., Chen, J., Ma, C., Sun, Z., & Pang, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113960 · Cited by 23
Fear of Cancer Recurrence and Sleep in Couples Coping With Early-Stage Breast Cancer
Perndorfer, C., Soriano, E. C., Siegel, S. D., Spencer, R. M. C., Otto, A. K., & Laurenceau, J.-P. (2022) · Annals of Behavioral Medicine · doi:10.1093/abm/kaac018 · Cited by 21
Measurement and Application of Incidentally Detected Coronary Calcium
Parsa, S., Saleh, A., Raygor, V., Hoeting, N., Rao, A., Navar, A. M., Rohatgi, A., Kay, F., Abbara, S., Khera, A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.01.039 · Cited by 23
Zheng, W., Hu, J., Lv, Y., Bai, B., Shan, L., Chen, K., Dai, S., & Zhu, H. (2021) · Medical Oncology · doi:10.1007/s12032-021-01472-3 · Cited by 21
Valle, C. G., Camp, L. N., Diamond, M., Nezami, B. T., LaRose, J. G., Pinto, B. M., & Tate, D. F. (2022) · Trials · doi:10.1186/s13063-022-06148-5 · Cited by 20
Iqbal, H., Inam‐Ur‐Raheem, M., Munir, S., Rabail, R., Kafeel, S., Shahid, A., Mousavi Khaneghah, A., & Aadil, R. M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.3869 · Cited by 19
Eaton, L. H., Beck, S. L., & Jensen, M. P. (2021) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2021.1951119 · Cited by 19
Leach, C. R., Diefenbach, M. A., Fleszar, S., Alfano, C. M., Stephens, R. L., Riehman, K., & Hudson, S. V. (2019) · Psycho-Oncology · doi:10.1002/pon.5193 · Cited by 18
Self-citationZahedian, E., Bahreini, M., Ghasemi, N., & Mirzaei, K. (2021) · BMC Women's Health · doi:10.1186/s12905-021-01258-9 · Cited by 17
Yimam, M. A., Andreini, M., Carnevale, S., & Muscaritoli, M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1461621 · Cited by 16
Machado, M. A. D. Á., de Moura, C. S., Chan, K., Curtis, J. R., Hudson, M., Abrahamowicz, M., Jamal, R., Pilote, L., & Bernatsky, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-71788-z · Cited by 14
Shi, Y., Zhou, J., Zhao, Y., Zhu, B., Zhang, L., Li, X., Fang, J., Shi, J., Zhuang, Z., Yang, S., et al. (2023) · BMC Medicine · doi:10.1186/s12916-022-02692-8 · Cited by 13
Employment changes among Chinese family caregivers of long-term cancer survivors
Liu, S., Su, M., Yao, N., Zhang, N., Wang, J., Anderson, R. T., & Sun, X. (2020) · BMC Public Health · doi:10.1186/s12889-020-09922-9 · Cited by 13
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities
Leach, C. R., Alfano, C. M., Potts, J., Gallicchio, L., Yabroff, K. R., Oeffinger, K. C., Hahn, E. E., Shulman, L. N., & Hudson, S. V. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa053 · Cited by 12
Self-citationLee, K. (2021) · European Journal of Cancer Care · doi:10.1111/ecc.13365 · Cited by 8
Booker, R., Bays, S., Burnett, L., & Torchetti, T. (2021) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2021.151169 · Cited by 8
Oppong, B. A., Lustberg, M. B., Nolan, T. S., Relation, T., Park, K. U., Healy, E., Trance, A., & Klemanski, D. L. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01231-x · Cited by 6
Goyal, N., Levine, B. J., Crawford, S. L., & Avis, N. E. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01247-3 · Cited by 4
“8 million breast cancer survivors (BCS) were alive on January 1, 2019 [2].”
Hwang, S., Bozkurt, B., Huson, T., Asad, S., Richardson, L., Ogbansiegbe, J. A., Viera, L., Buse, C., James, T. A., Mayer, D. K., et al. (2022) · JCO Oncology Practice · doi:10.1200/op.21.00357 · Cited by 2
Metadata
- Authors
- Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2019-06-11
- Volume
- 69
- Issue
- 5
- Pages
- 363-385
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2951071083
- Cited by
- 4,226
- References
- 26
- FWCI
- 250.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.